Downregulation of caspase 3 expression in the examined RA patients to the level of healthy subjects after RTX therapy contradicts the notion that stimulation of apoptosis could be one of the mechanisms for RTX-mediated B-cell elimination [39] and supports a belief that the ability of RTX to induce apoptosis is very low [40]. This evidence concerns the gene CASP3 and rheumatoid arthritis.